TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/25 16:17 | 2/19/25 | SLDB | Solid Biosciences Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 2 | P | 39,011 | 4.64 | 0 | 8,411 | 241 | 11,907 | I | ||||||||||||||
8/14/24 18:54 | 8/12/24 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | P | 5,000 | 4.00 | 0 | 1,250 | 11 | 12,531 | I | ||||||||||||||
4/15/24 08:53 | 4/11/24 | ACRV | Acrivon Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 20,001 | 8.50 | 0 | 2,353 | 78 | 5,361 | I | |||||||||||||||
4/8/24 17:32 | 4/4/24 | ALDX | Aldeyra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | P.m | 2,768 | 4.06 | 0 | 682 | 8 | 9,276 | I | ||||||||||||||
2/5/24 17:02 | 2/1/24 | ATXS | Astria Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | P | 34,588 | 10.74 | 0 | 3,221 | 99 | 6,485 | I | ||||||||||||||
12/29/23 17:27 | 12/27/23 | VRCA | Verrica Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 3 | P.m | 12,503 | 6.07 | 0 | 2,060 | 41 | 7,099 | I | ||||||||||||||
12/29/23 17:24 | 12/27/23 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | P.m | 1,463 | 2.42 | 0 | 606 | 13 | 5,403 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |